Ardsley Advisory Partners’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-21
| Closed | -$75K | – | 177 |
|
|
2020
Q3 | $75K | Hold |
21
| – | – | 0.01% | 119 |
|
|
2020
Q2 | $81K | Buy |
21
+3
| +17% | +$11.6K | 0.02% | 110 |
|
|
2020
Q1 | $34K | Buy |
18
+5
| +38% | +$9.44K | 0.01% | 88 |
|
|
2019
Q4 | $67K | Hold |
13
| – | – | 0.01% | 123 |
|
|
2019
Q3 | $46K | Hold |
13
| – | – | 0.01% | 106 |
|
|
2019
Q2 | $110K | Buy |
13
+3
| +30% | +$25.4K | 0.02% | 122 |
|
|
2019
Q1 | $134K | Buy |
10
+9
| +900% | +$121K | 0.03% | 109 |
|
|
2018
Q4 | $29K | Hold |
1
| – | – | 0.01% | 94 |
|
|
2018
Q3 | $31K | Buy |
+1
| New | +$31K | ﹤0.01% | 133 |
|